SciELO - Scientific Electronic Library Online

 
vol.51 issue1Resistin is associated with C reactive protein and cardiovascular risk markers in obese childrenComparison of manual microscope method and an automated cell count in serous fluids author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Acta bioquímica clínica latinoamericana

On-line version ISSN 1851-6114

Abstract

ARISTIMUNO, Ana María et al. Cross-reactivity of a screening test for celiac disease with other autoantibodies. Acta bioquím. clín. latinoam. [online]. 2017, vol.51, n.1, pp. 29-35. ISSN 1851-6114.

The goal of this study was to show the presence of cross-reactivity screening test htTG/DGP for celiac disease (CD) with other autoantibodies present in high titers in different autoimmune diseases (AD). A cross-sectional study was performed for which 100 patients of both sexes (15 men, 85 women), aged between 4 and 86 years without CD who had different autoimmune pathologies were selected. To study the presence of CD, QUANTALite® (INOVA Diagnostics, USA): htTG/DGP Screen, htTG IgA and IgG, Gliadin IgAII and IgGII tests by ELISA were used. Other autoantibodies from AD were determined by indirect immunofluorescence and by electrochemiluminescence. Cross-reactivity with non-specific autoantibodies found in EC was 2.0%. The two positive samples of screening test (23,0 U and 24,9 U) had anti-centromere antibodies 1/1280 and anti-nuclear antibodies 1/640 respectively. They were analyzed for celiac disease markers and only one was weak positive (21,8 U) for anti-Gliadin IgAII. The low cross reactivity found with screening test htTG/DGP in the presence of other autoantibodies made it possible to conclude that this test is a useful tool for screening of CD in patients with different autoimmune diseases.

Keywords : Autoantibodies; Celiac disease; Screening test.

        · abstract in Spanish | Portuguese     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License